GlassScriptPhysician profile
George Yousef
NPI 1104180512
$9,954.93
in general payments reported to CMS, 2019-2025
30 companies · $3,721 in 2025
The $3,721 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,602 · 2020: $561 · 2021: $288 · 2022: $1,807 · 2023: $1,076 · 2024: $900 · 2025: $3,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301 · Travel and Lodging: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,300.81 |
| Travel and Lodging | $1,396.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,376.53 | 2023-2025 | Indigo System, Penumbra System, Ruby Coil |
| Bard Peripheral Vascular, INC. | $1,666.19 | 2020-2022 | |
| Boston Scientific Corporation | $1,253.20 | 2019-2025 | Eluvia, Rubicon 18, Wolverine Coronary Cutting Balloon |
| E.R. Squibb & Sons, L.L.C. | $643.17 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $640.67 | 2020-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $374.15 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $355.44 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $283.50 | 2019-2020 | |
| Shockwave Medical, INC | $252.95 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $252.32 | 2025 | Flowtriever, Artix Mt, Flowtriever Catheter, S |
| Endologix LLC | $251.95 | 2025 | Torus Stent Graft System, Endocross Device |
| Abbott Laboratories | $232.73 | 2019-2025 | Cardiomems, Emboshield Nav6 |
| Amgen INC. | $205.72 | 2019-2025 | Repatha, Repatha |
| Reflow Medical INC | $174.21 | 2023 | |
| Philips North America LLC | $148.09 | 2020-2025 | Coronary Other, Labosys |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $145.79 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $141.43 | 2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $115.79 | 2019-2023 | Farxiga |
| Acist Medical Systems, INC. | $80.81 | 2025 | |
| Merck Sharp & Dohme LLC | $72.19 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.43 | 2022-2025 | Jardiance |
| Novo Nordisk INC | $47.07 | 2023-2025 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals, LTD. | $30.13 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $28.80 | 2025 | Assure Wcd |
| W. L. Gore & Associates, INC. | $28.05 | 2025 | Gore Viabahn Endoprosthesis With Heparin |
| Irhythm Technologies, INC. | $24.47 | 2024 | Zio Monitor, Zio Xt Patch |
| Medtronic, INC. | $18.92 | 2022 | |
| Surmodics, INC. | $18.00 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Glaxosmithkline, LLC. | $17.70 | 2023 | Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $15.53 | 2024 | Libtayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Yousef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.